Structure-activity relationship of ghrelin: Pharmacological study of ghrelin peptides

被引:213
作者
Matsumoto, M
Hosoda, H
Kitajima, Y
Morozumi, N
Minamitake, Y
Tanaka, S
Matsuo, H
Kojima, M
Hayashi, Y
Kangawa, K
机构
[1] Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan
[2] Suntory Inst Med Res & Dev, Akaiwa, Gunma 3700503, Japan
[3] Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan
基金
日本科学技术振兴机构;
关键词
ghrelin; growth hormone; growth hormone secretagogue; peptide modification; lipid modification; acyl acid; peptide synthesis;
D O I
10.1006/bbrc.2001.5553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ghrelin, a novel peptide purified from the stomach, is the endogenous ligand of the growth hormone secretagogue receptor. The Sera residue of ghrelin is modified with a lipid n-octanoic acid, a modification necessary for hormonal activity. To clarify the role of acyl modification and to identify the active core of ghrelin, we examined the activities of partially digested ghrelin and synthetic ghrelin derivatives. The activities confirmed that the N-terminal portion is the active core. Moreover, synthetic ghrelin derivatives demonstrated that octanoic acid is not the only modification of the Ser(3) side chain to sustain the activity of ghrelin; other acyl acid modifications maintained activity. Amino acid replacement of Sera indicated that an L-configuration of the third residue is critical for ghrelin activity. In addition, more stable ether or thioether bonds are capable of replacing the octanoyl ester bond in ghrelin, advantageous for the generation of pharmaceuticals with longer stability. (C) 2001 Academic Press.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 10 条
[1]   Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans [J].
Arvat, E ;
Di Vito, L ;
Broglio, F ;
Papotti, M ;
Muccioli, G ;
Dieguez, C ;
Casanueva, FF ;
Deghenghi, R ;
Camanni, F ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (08) :493-495
[2]   Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a [J].
Bednarek, MA ;
Feighner, SD ;
Pong, SS ;
McKee, KK ;
Hreniuk, DL ;
Silva, MV ;
Warren, VA ;
Howard, AD ;
Van der Ploeg, LHY ;
Heck, JV .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4370-4376
[3]   9-FLUORENYLMETHOXYCARBONYL AMINO-PROTECTING GROUP [J].
CARPINO, LA ;
HAN, GY .
JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (22) :3404-&
[4]  
CHANG CD, 1980, INT J PEPT PROT RES, V15, P485
[5]   Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor [J].
Hosoda, H ;
Kojima, M ;
Matsuo, H ;
Kangawa, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :21995-22000
[6]   Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J].
Kojima, M ;
Hosoda, H ;
Date, Y ;
Nakazato, M ;
Matsuo, H ;
Kangawa, K .
NATURE, 1999, 402 (6762) :656-660
[7]   Peptidomimetic growth hormone secretagogues. Design considerations and therapeutic potential [J].
Nargund, RP ;
Patchett, AA ;
Bach, MA ;
Murphy, MG ;
Smith, RG .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) :3103-3127
[8]  
PERINO R, 2000, EUR J ENDOCRINOL, V143, pR11
[9]  
Schroeder K.S., 1996, J BIOMOL SCREEN, V1, P75
[10]   Ghrelin strongly stimulates growth hormone (GH) release in humans [J].
Takaya, K ;
Ariyasu, H ;
Kanamoto, N ;
Iwakura, H ;
Yoshimoto, A ;
Harada, M ;
Mori, K ;
Komatsu, Y ;
Usui, T ;
Shimatsu, A ;
Ogawa, Y ;
Hosoda, K ;
Akamizu, T ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4908-4911